Post Mortem Articles & Analysis
4 news found
Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company with successful "first-in-human" experience in esophageal cancer and FDA approval to commence a clinical trial of its Biostage Esophageal Implant for esophageal disease, today announced it has hired David Green as its Chief Executive Officer and appointed Mr. Green as Chairman of the Board of Directors (the ...
Previous studies have demonstrated the increased prevalence of unstable plaques post-mortem, but performing this characterization from non-invasive imaging for the first time enables widespread usage to predict and prevent adverse events, such as heart attack and stroke. ...
ByElucid
The TRACERx study focuses on cancer evolution in lung cancer patients and tracking the evolutionary trajectory of the disease from diagnosis through to relapse. The PEACE study accepts post-mortem tissue donation for comprehensive cancer research with the aim to benefit future patients. ...
How AI Can Improve CTA Analysis After Stroke and Heart Attack Originally posted on MDDI Online, Written by Amanda Pedersen Computed tomography angiography (CTA) has been increasingly used in the diagnosis of vascular disease, and it’s a modality that offers many potential clinical benefits. ...
ByElucid